Literature DB >> 3264791

Histological signs of immune reactions against allogeneic solid fetal neural grafts in the mouse cerebellum depend on the MHC locus.

I Date1, K Kawamura, H Nakashima.   

Abstract

Using an immunocytochemical method, we examined the immunological responses of adult mice to intracerebellar syngeneic and allogeneic fetal mouse brainstem transplants (embryonic days 12-14). Syngeneic grafts and major histocompatibility complex (MHC)-compatible and non-MHC-incompatible allogeneic grafts survived well, showing no histological signs of rejection even 6 months after transplantation, and with no expression of MHC antigens being observed in any of the grafts. However, most cases of both MHC- and non-MHC-incompatible allografts showed rejection responses, such as marked neovascularization, cellular infiltration and necrosis, two weeks to one month after transplantation. In animals showing rejection, Class I MHC antigens were found on grafted neuronal tissue. An increased number of reactive astrocytes was also observed in the grafts. High levels of Class I antigen expression and prominent gliosis correlated with vigorous cellular infiltration. A quantitative analysis of T cell subsets in the animals showing rejection revealed that the L3T4/Lyt-2 ratio was 1.02 +/- 0.21 (mean +/- S.D.), indicating that helper/inducer and cytotoxic/suppressor T cells appeared equally in the rejection of MHC- and non-MHC-incompatible allografts. We consider that in these experiments, the brain was not completely an immunologically privileged site, and that MHC- and non-MHC-incompatible intraparenchymal neural transplants were not shielded from host immune surveillance.

Entities:  

Mesh:

Year:  1988        PMID: 3264791     DOI: 10.1007/bf00279656

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  39 in total

1.  Astrocytes as antigen-presenting cells. I. Induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation.

Authors:  W Fierz; B Endler; K Reske; H Wekerle; A Fontana
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

2.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

3.  Mononuclear cells in renal allografts. Correlation with peripheral blood T lymphocyte subpopulations and graft prognosis.

Authors:  A van Es; C J Meyer; P J Oljans; H J Tanke; L A van Es
Journal:  Transplantation       Date:  1984-02       Impact factor: 4.939

Review 4.  Interferon-gamma induces the expression of H-2 and Ia antigens on brain cells.

Authors:  G H Wong; P F Bartlett; I Clark-Lewis; J L McKimm-Breschkin; J W Schrader
Journal:  J Neuroimmunol       Date:  1985 Feb-Mar       Impact factor: 3.478

5.  Mouse nervous tissue iso-antigens.

Authors:  A E Reif; J M Allen
Journal:  Nature       Date:  1966-01-29       Impact factor: 49.962

6.  Functional capacity of solid tissue transplants in the brain: evidence for immunological privilege.

Authors:  J R Head; W S Griffin
Journal:  Proc R Soc Lond B Biol Sci       Date:  1985-05-22

7.  Cyclosporin A enhances the survivability of mouse cerebral cortex grafted into the third ventricle of rat brain.

Authors:  H Inoue; S Kohsaka; K Yoshida; M Ohtani; S Toya; Y Tsukada
Journal:  Neurosci Lett       Date:  1985-02-28       Impact factor: 3.046

8.  Astrocyte-derived interleukin 3 as a growth factor for microglia cells and peritoneal macrophages.

Authors:  K Frei; S Bodmer; C Schwerdel; A Fontana
Journal:  J Immunol       Date:  1986-12-01       Impact factor: 5.422

9.  Specific patterns of fibre outgrowth from transplants to host mice hippocampi, shown immunohistochemically by the use of allelic forms of Thy-1.

Authors:  C F Zhou; G Raisman; R J Morris
Journal:  Neuroscience       Date:  1985-12       Impact factor: 3.590

10.  On the presence of Ia-positive endothelial cells and astrocytes in multiple sclerosis lesions and its relevance to antigen presentation.

Authors:  U Traugott; L C Scheinberg; C S Raine
Journal:  J Neuroimmunol       Date:  1985-04       Impact factor: 3.478

View more
  8 in total

Review 1.  Neural transplantation for Parkinson's disease.

Authors:  I Date; T Ohmoto
Journal:  Cell Mol Neurobiol       Date:  1999-02       Impact factor: 5.046

2.  Temporal pattern of host responses against intrastriatal grafts of syngeneic, allogeneic or xenogeneic embryonic neuronal tissue in rats.

Authors:  W M Duan; H Widner; P Brundin
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

3.  Immune response to murine cell lines of glial origin transplanted into the central nervous system of adult mice.

Authors:  L A Terry; E J Usherwood; S Lees; N MacIntyre; A A Nash
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

4.  Cytotoxic T cells isolated from the central nervous systems of mice infected with Theiler's virus.

Authors:  M D Lindsley; R Thiemann; M Rodriguez
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

5.  Survival and immunogenicity of dissociated allogeneic fetal neural dopamine-rich grafts when implanted into the brains of adult mice.

Authors:  H Widner; P Brundin; A Björklund; E Möller
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

6.  Rat brain xenografts reverse hypogonadism in mice immunosuppressed with anti-CD4 monoclonal antibody.

Authors:  C R Honey; H M Charlton; K J Wood
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

7.  Banking on iPSC--is it doable and is it worthwhile.

Authors:  Susan Solomon; Fernando Pitossi; Mahendra S Rao
Journal:  Stem Cell Rev Rep       Date:  2015-02       Impact factor: 5.739

Review 8.  Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis.

Authors:  H Widner; P Brundin
Journal:  Brain Res       Date:  1988-11       Impact factor: 3.252

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.